PCM
PRTK

Penserra Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Penserra Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,110
Closed -$5K – 1605
2021
Q3 		$5K Buy
1,110
+40
+4% +$180 ﹤0.01% 1415
2021
Q2 		$7K Buy
1,070
+20
+2% +$131 ﹤0.01% 1303
2021
Q1 		$7K Hold
1,050
– – ﹤0.01% 1067
2020
Q4 		$6K Buy
+1,050
New +$6K ﹤0.01% 979